Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anecortave Acetate for Steroid-Induced IOP Elevation
NCT00315640Phase 2Completed
- Sponsor
- Alcon Inc.
- Start
- Dec 2005
- Primary completion
- Jul 2009
- Modality
- Orthosteric Ligands
- Countries
- 8
01
Overview
A Phase 2 trial of anecortave in ocular hypertension, sponsored by Alcon Inc.. Started Dec 2005; status: completed.
02
Drugs
anecortave
03
Conditions
ocular hypertension
Beyond the preview
Go deeper on NCT00315640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00315640.